Menstrual Cycle-induced Pain, Fatigue and Anxiety in Women Suffered From COVID-19

NCT04806815 | Completed

• 1 other identifier: 2021/47-45
• Study Type: observational
• Target: 180
• Locations: 1 country
• Sites: 1

Brief Summary

The effects of COVID-19 on body systems and functions are still being investigated. ACE 2, which plays a key role in the entry of the COVID-19 virus into the cell, is also highly expressed in the ovary, uterus, vagina, and placenta in the female genital system, which can also pose a risk to female reproductive health. The aim of this study is to evaluate menstrual cycle-induced pain, fatigue and anxiety in women who suffered from COVID-19.

Conditions

Menstrual Problem; Covid19; Fatigue

Keywords

Menstrual Problem; Covid19; Fatigue

Outcome Measures

Primary Outcomes (1)

• Menstrual Symptom Questionnaire

  This scale was developed to assess menstrual pain and symptoms. It is a five-point Likert-type scale consisting of 24 items. Participants will be asked to give a number between 1 (never) and 5 (always) to their menstrual symptoms. Total score will be calculated by taking the total score of the items in the scale. Increasing the average score indicates that the severity of menstrual symptoms increased.

  1 day

Secondary Outcomes (2)

• Fatigue Severity Scale

  1 day

• Short Form Of Coronavirus Anxiety Scale

  1 day

Interventions

A survey of 60 questions was created through the internet-based 'Google Forms surveys' site. OTHER

The following tests will be used together with the survey; * Menstrual Symptom Questionnaire * Fatigue Severity Scale * Short Form Of Coronavirus Anxiety Scale

Eligibility Criteria

• Age: 18 Years - 45 Years
• Gender Eligibility Details: female individuals aged 18-45 who have had COVID-19
• Age Groups: Adult (18-64)
• Sampling Method: Probability Sample

Study Population

The study will include 200 volunteers, female individuals aged 18-45 who have had COVID-19.

You may qualify if:

• Being between the ages of 18 and 45,
• PCR test result positive confirmed having COVID-19 infection,
• Women had at least one period of Menstrual cycle after COVID-19
• Being an Internet connection,
• To be able to speak and write in Turkish.

You may not qualify if:

• To be in the premenaposual/postmenopausal period (to be in the transition period to menopause or in the period after menopause.)
• Having insufficient co-operation.

Sponsors & Collaborators

• Biruni University: lead

Study Sites (1)

Biruni University

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Menstruation Disturbances; COVID-19; Fatigue

Condition Hierarchy (Ancestors)

Pathologic Processes; Pathological Conditions, Signs and Symptoms; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Signs and Symptoms

Study Officials

• Buket Akinci

  Biruni University

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: OTHER
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associated Proffesor

Study Record Dates

• First Submitted: March 17, 2021
• First Posted: March 19, 2021
• Study Start: May 18, 2021
• Primary Completion: May 30, 2021
• Study Completion: June 1, 2021
• Last Updated: June 30, 2021

Record last verified: 2021-06

Locations

TU (1)